Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xianyu Qin

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Life Sciences|December 1, 2020
Systematic analysis of molecular mechanisms of heart failure through the pathway and network-based approachKai Zhang, Xianyu Qin, Pengju Wen, et al.
DNA and Cell Biology|February 19, 2021
Asporin is a Potential Promising Biomarker for Common Heart FailureKai Zhang, Min Wu, Xianyu Qin, et al.
Journal of Ethnopharmacology|December 10, 2020
Global gene expression analysis using RNA-seq reveals the new roles of Panax notoginseng Saponins in ischemic cardiomyocytesShaoxian Chen, Yueheng Wu, Xianyu Qin, et al.
Frontiers in Cardiovascular Medicine|March 13, 2023
Systematic analysis of myocardial immune progression in septic cardiomyopathy: Immune-related mechanisms in septic cardiomyopathyDunliang Ma, Xianyu Qin, Zhi-An Zhong, et al.
BMC Medical Genomics|August 7, 2021
Multi-factor regulatory network and different clusters in hypertrophic obstructive cardiomyopathyXianyu Qin, Lei Huang, Sicheng Chen, et al.
BMC Medical Genomics|April 22, 2024
Analysis of cancer-associated fibroblasts related genes identifies COL11A1 associated with lung adenocarcinoma prognosisHaosheng Zheng, Jian Tan, Fei Qin, et al.
Frontiers in Pharmacology|January 25, 2024
Addition of bevacizumab to EGFR tyrosine kinase inhibitors in advanced NSCLC: an updated systematic review and meta-analysisHaosheng Zheng, Xianyu Qin, Yuzhen Zheng, et al.
Cancers|November 11, 2022
Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and ImmunotherapyHaosheng Zheng, Guojie Long, Yuzhen Zheng, et al.
Cancers|February 11, 2023
Correction: Zheng et al. Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy. <i>Cancers</i> 2022, <i>14</i>, 5344Haosheng Zheng, Guojie Long, Yuzhen Zheng, et al.
Scientific Reports|April 26, 2025
PKM2 modulates chemotherapy sensitivity by regulating autophagy and predicts the prognosis and immunity in pancancerHaosheng Zheng, Jian Tan, Fei Qin, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Life Sciences|December 1, 2020
Systematic analysis of molecular mechanisms of heart failure through the pathway and network-based approachKai Zhang, Xianyu Qin, Pengju Wen, et al.
DNA and Cell Biology|February 19, 2021
Asporin is a Potential Promising Biomarker for Common Heart FailureKai Zhang, Min Wu, Xianyu Qin, et al.
Journal of Ethnopharmacology|December 10, 2020
Global gene expression analysis using RNA-seq reveals the new roles of Panax notoginseng Saponins in ischemic cardiomyocytesShaoxian Chen, Yueheng Wu, Xianyu Qin, et al.
Frontiers in Cardiovascular Medicine|March 13, 2023
Systematic analysis of myocardial immune progression in septic cardiomyopathy: Immune-related mechanisms in septic cardiomyopathyDunliang Ma, Xianyu Qin, Zhi-An Zhong, et al.
BMC Medical Genomics|August 7, 2021
Multi-factor regulatory network and different clusters in hypertrophic obstructive cardiomyopathyXianyu Qin, Lei Huang, Sicheng Chen, et al.
BMC Medical Genomics|April 22, 2024
Analysis of cancer-associated fibroblasts related genes identifies COL11A1 associated with lung adenocarcinoma prognosisHaosheng Zheng, Jian Tan, Fei Qin, et al.
Frontiers in Pharmacology|January 25, 2024
Addition of bevacizumab to EGFR tyrosine kinase inhibitors in advanced NSCLC: an updated systematic review and meta-analysisHaosheng Zheng, Xianyu Qin, Yuzhen Zheng, et al.
Cancers|November 11, 2022
Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and ImmunotherapyHaosheng Zheng, Guojie Long, Yuzhen Zheng, et al.
Cancers|February 11, 2023
Correction: Zheng et al. Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy. <i>Cancers</i> 2022, <i>14</i>, 5344Haosheng Zheng, Guojie Long, Yuzhen Zheng, et al.
Scientific Reports|April 26, 2025
PKM2 modulates chemotherapy sensitivity by regulating autophagy and predicts the prognosis and immunity in pancancerHaosheng Zheng, Jian Tan, Fei Qin, et al.
Pageof 2